Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
Cummings JL, Koumaras B, Chen M, Mirski D; Rivastigmine Nursing Home Study Team. Cummings JL, et al. Among authors: mirski d. Am J Geriatr Pharmacother. 2005 Sep;3(3):137-48. doi: 10.1016/s1543-5946(05)80020-0. Am J Geriatr Pharmacother. 2005. PMID: 16257816 Clinical Trial.
The use of the occupational disruptiveness scale of the neuropsychiatric inventory-nursing home version to measure the impact of rivastigmine on the disruptive behavior of nursing home residents with Alzheimer's disease.
Hatoum HT, Lin SJ, Arcona S, Thomas SK, Koumaras B, Mirski D. Hatoum HT, et al. Among authors: mirski d. J Am Med Dir Assoc. 2005 Jul-Aug;6(4):238-45. doi: 10.1016/j.jamda.2005.04.003. J Am Med Dir Assoc. 2005. PMID: 16005409 Clinical Trial.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page